We are live on ! Find out more
TCIM

TIAA CREF Investment Management Portfolio holdings

AUM $141B
1-Year Est. Return 14.18%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.07%
5 Year Est. Return
+108.37%
10 Year Est. Return
AUM
$141B
AUM Growth
+$15B
Cap. Flow
-$3.33B
Cap. Flow %
-2.36%
Top 10 Hldgs %
20.05%
Holding
3,067
New
60
Increased
1,132
Reduced
1,578
Closed
64

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$493M
2
MSFT icon
Microsoft
MSFT
+$336M
3
NOC icon
Northrop Grumman
NOC
+$224M
4
NVDA icon
NVIDIA
NVDA
+$208M
5
MAR icon
Marriott International
MAR
+$202M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Financials 14.22%
3 Healthcare 13.74%
4 Consumer Discretionary 11.39%
5 Communication Services 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABUS icon
2826
Arbutus Biopharma
ABUS
$847M
$247K ﹤0.01%
69,076
-27
-0% -$104
FDBC icon
2827
Fidelity D&D Bancorp
FDBC
$308M
$247K ﹤0.01%
4,176
+78
+2% +$4.69K
FONR
2828
DELISTED
Fonar
FONR
$247K ﹤0.01%
12,086
-261
-2% -$5.67K
FFNW
2829
DELISTED
First Financial Northwest, Inc
FFNW
$247K ﹤0.01%
15,676
MLVF
2830
DELISTED
Malvern Bancorp, Inc.
MLVF
$246K ﹤0.01%
12,225
+462
+4% +$9.48K
PMBC
2831
DELISTED
Pacific Mercantile Bancorp
PMBC
$246K ﹤0.01%
32,325
ARA
2832
DELISTED
American Renal Associates Holdings, Inc
ARA
$246K ﹤0.01%
40,112
RTW
2833
DELISTED
RTW Retailwinds, Inc.
RTW
$246K ﹤0.01%
102,508
-3,325
-3% -$9.71K
NEOS
2834
DELISTED
Neos Therapeutics, Inc
NEOS
$245K ﹤0.01%
93,684
+25,715
+38% +$60.3K
IOTS
2835
DELISTED
Adesto Technologies Corp
IOTS
$245K ﹤0.01%
40,569
+15,599
+62% +$86.8K
INSY
2836
DELISTED
Insys Therapeutics, Inc.
INSY
$245K ﹤0.01%
52,971
+1,194
+2% +$5.65K
STIM icon
2837
Neuronetics
STIM
$127M
$241K ﹤0.01%
+15,814
New +$262K
ESCA icon
2838
Escalade
ESCA
$271M
$240K ﹤0.01%
21,483
RAIL icon
2839
FreightCar America
RAIL
$263M
$238K ﹤0.01%
38,569
+22
+0.1% +$162
CURO
2840
DELISTED
CURO Group Holdings Corp.
CURO
$238K ﹤0.01%
23,775
CBUS icon
2841
Cibus
CBUS
$148M
$236K ﹤0.01%
269
CUE icon
2842
Cue Biopharma
CUE
$118M
$236K ﹤0.01%
1,017
-337
-25% -$64.1K
LAND
2843
Gladstone Land Corp
LAND
$365M
$236K ﹤0.01%
18,672
OCUL icon
2844
Ocular Therapeutix
OCUL
$1.83B
$236K ﹤0.01%
59,473
-20,930
-26% -$84.1K
PYX
2845
DELISTED
Pyxus International, Inc.
PYX
$236K ﹤0.01%
+9,871
New +$206K
PRGX
2846
DELISTED
PRGX Global, Inc.
PRGX
$235K ﹤0.01%
29,711
PTN
2847
Palatin Technologies
PTN
$14.4M
$230K ﹤0.01%
188
CSTR
2848
DELISTED
CapStar Financial Holdings, Inc
CSTR
$230K ﹤0.01%
15,902
+1,000
+7% +$15.7K
MBCN
2849
DELISTED
Middlefield Banc Corp
MBCN
$229K ﹤0.01%
11,104
SONO icon
2850
Sonos
SONO
$2.09B
$229K ﹤0.01%
22,266

Similar funds

TIAA CREF Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, TIAA CREF Investment Management held 3,067 positions worth $141B, up 12% from $126B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4%. TIAA CREF Investment Management opened 60 new positions and exited 64, leaving the 3,067-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • TIAA CREF Investment Management's largest Q1 2019 buy was Takeda Pharmaceutical: 6,555,742 shares worth $134M.
  • TIAA CREF Investment Management added most to Meta Platforms (Facebook) in Q1 2019, an estimated $253M increase.
  • TIAA CREF Investment Management's biggest Q1 2019 reduction was JPMorgan Chase, cutting an estimated $493M.
  • TIAA CREF Investment Management fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $165M.
  • TIAA CREF Investment Management's ten largest holdings make up 20% of its $141B portfolio in Q1 2019.
  • TIAA CREF Investment Management opened 60 new positions and closed 64 in Q1 2019.
  • TIAA CREF Investment Management's portfolio value rose 12% quarter-over-quarter to $141B.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.